You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

Table 1.  

Covariate, n (row %) Sucess Failure Total p-value
Overall >4741 (85.1) 767 (13.9) 5508 N/A
Patient age (years)
   <45 290 (80.6) 70 (19.4) 360 <0.001
   45 to 64 2549 (88.7) 324 (11.3) 2873
   65 to 79 1642 (84.7) 297 (15.3) 1939
   ≥80 260 (77.4) 76 (22.6) 336
Patient gender
   Male 3008 (85.6) 506 (14.4) 3514 0.177
   Female 1733 (86.9) 261 (13.1) 1994
Lens status
   No previous cataract surgery 3151 (87.3) 460 (12.7) 3611 0.002
   Previous cataract surgery 1374 (84.0) 261 (16.0) 1635
   Combined phaco vitrectomy 216 (82.4) 46 (17.6) 262
Foveal status
   Attached 2210 (90.1) 242 (9.9) 2452 <0.001
   Detached 2519 (82.8) 522 (17.2) 3041
   Not recorded 12 (80.0) 3 (20.0) 15
Number of breaks in the attached retina
   None 3359 (84.8) 601 (15.2) 3960 0.001
   1 break 660 (89.4 78 (10.6) 738
   2 breaks 312 (87.6) 44 (12.4) 356
   3 breaks 201 (89.3) 24 (10.7) 225
   >3 breaks 209 (91.3) 20 (8.7) 229
Number of breaks in the detached retina
   None 14 (82.4) 3 (17.6) 17 0.008
   1 break 2147 (87.5) 306 (12.5) 2453
   2 breaks 1113 (85.2) 194 (14.8) 1307
   3 breaks 685 (86.9) 103 (13.1) 788
   >3 breaks 782 (82.9) 161 (17.1) 943
Location of largest break
   9 – 3 O’clock 3547 (89.0) 438 (11.0) 3985 <0.001
   4 or 8 O ’clock 477 (82.7) 100 (17.3) 577
   5 – 7 O’clock 703 (75.7) 226 (24.3) 929
   No break found 14 (82.4) 3 (17.6) 17
Superior clock hours detached
   <3 h 1558 (86.4) 245 (13.6) 1803 <0.001
   3 to 5 h 2673 (88.8) 338 (11.2) 3011
   6 h 510 (73.5) 184 (26.5) 694
Inferior clock hours detached
   <3 h 2997 (91.3) 284 (8.7) 3281 <0.001
   3 to 5 h 1068 (82.7) 224 (17.3) 1292
   6 h 676 (72.3) 259 (27.7) 935
Total RD
   No 4502 (87.9) 620 (12.1) 5122 <0.001
   Yes 239 (61.9) 147 (38.1) 386
Largest break type
   Not found 33 (71.7) 13 (28.3) 46 <0.001
   U tear 4162 (86.9) 627 (13.1) 4789
   Round hole 330 (81.7) 74 (18.3) 404
   Dialysis 32 (88.9) 4 (11.1) 36
   Giant Retinal Tear 137 (83.0) 28 (17.0) 165
   Macular hole 3 (42.9) 4 (57.1) 7
   Outer leaf break 44 (72.1) 17 (27.9) 61
Schisis RD
   Absent 4697 (86.2) 750 (13.8) 5447 0.002
   Present 44 (72.1) 17 (27.9) 61
PVR grade
   None, A or B 4456 (88.1) 602 (11.9) 5058 <0.001
   > = C 285 (63.3) 165 (36.7) 450
Laser photocoagulation used during surgery
   No 2929 (88.9) 367 (11.1) 3296 <0.001
   Yes 1812 (81.9) 400 (18.1) 2212
Cryotherapy used during surgery
   No 764 (78.2) 213 (21.8) 977 <0.001
   Yes 3977 (87.8) 554 (12.2) 4531
Tamponade used during surgery
   Sulphur hexafluoride gas 2268 (89.9) 256 (10.1) 2524 <0.001
   Perfluoroethane gas 1538 (89.9) 173 (10.1) 1711
   Perfluoropropane gas 558 (81.9) 123 (18.1) 681
   Air 42 (89.4) 5 (10.6) 47
   Light oil 265 (59.3) 182 (40.7) 447
   Heavy oil 70 (71.4) 28 (28.6) 98
Vitrectomy gauge used
   20 g 143 (74.5) 49 (25.5) 192 <0.001
   23 g 2809 (84.5) 515 (15.5) 3324
   25 g 1618 (89.9) 181 (10.1) 1799
   27 g 78 (88.6) 10 (11.4) 88
   Not recorded 93 (88.6) 12 (11.4) 105
Sub-retinal fluid drainage route
   Retinotomy 755 (84.4) 140 (15.6) 895 0.266
   Through the break 3208 (86.4) 506 (13.6) 3,714
   None/not recorded/other 778 (86.5) 121 (13.5) 899
Patient post-surgery posture position
   None 1149 (86.1) 186 (13.9) 1335 0.640
   Prone 1756 (86.2) 281 (13.8) 2037
   Upright 1048 (85.1) 183 (14.9) 1231
   Other 788 (87.1) 117 (12.9) 905
Age-related Macular Degeneration
   Absent 4704 (86.2) 750 (13.8) 5454 <0.001
   Present 37 (68.5) 17 (31.5) 54
Amblyopia
   Absent 4677 (86.2) 748 (13.8) 5425 0.017
   Present 64 (77.1) 19 (22.9) 83
Glaucoma
   Absent 4679 (86.1) 753 (13.9) 5432 0.254
   Present 62 (81.6) 14 (18.4) 76
High Myopia
   Absent 4491 (86.0) 729 (14.0) 5220 0.713
   Present 250 (86.8) 38 (13.2) 288

Table 1. Univariate analysis of covariates considered for the primary RD surgery failure model.

Table 2.  

Covariate Odds ratio Coefficient p-value 95% CI for the odds ratio
Constant 0.120 –1.611 <0.001 0.088 to 0.452
Patient age (years)
   45 to 64 Ref Ref N/A N/A
   65 to 79 1.266 0.236 0.005 1.076 to 1.490
   ≥80 1.645 0.498 0.001 1.221 to 2.218
   <45 1.583 0.459 0.004 1.154 to 2.171
Location of lowest break
   9–3 O’clock Ref Ref N/A N/A
   4 or 8 O’clock 1.533 0.428 0.002 1.171 to 2.008
   5–7 O’clock 1.835 0.607 <0.001 1.505 to 2.237
   No break found 1.966 0.676 0.242 0.634 to 6.100
Inferior clock hours detached
   <3 h Ref Ref N/A N/A
   3 to 5 h 1.554 0.441 <0.001 1.259 to 1.918
   6 h 1.545 0.435 0.005 1.143 to 2.089
Total Rd
   No Ref Ref N/A N/A
   Yes 1.941 0.663 <0.001 1.411 to 2.668
PVR grade
   None, A or B Ref Ref N/A N/A
   C 1.247 0.220 <0.001 1.133 to 1.372
Cryotherapy used during surgery
   No Ref Ref Ref Ref
   Yes 0.657 –0.420 0.011 0.476 to 0.908
Tamponade used during surgery
   Sulphur hexafluoride gas Ref Ref Ref Ref
   Perfluoroethane gas 0.659 –0.417 0.006 0.490 to 0.887
   Perfluoropropane gas 0.901 –0.104 0.473 0.678 to 1.198
   Air 0.853 –0.159 0.752 0.319 to 2.284
   Light oil 1.954 0.670 <0.001 1.361 to 2.805
   Heavy oil 1.031 0.030 0.931 0.522 to 2.037
Vitrectomy gauge used
   20 g Ref Ref Ref Ref
   23 g 0.665 –0.408 0.258 0.327 to 1.349
   25 g 0.413 –0.885 0.014 0.204 to 0.834
   27 g 0.495 –0.703 0.132 0.198 to 1.127
   CELL 0.478 –0.738 0.123 0.187 to 1.223

Table 2. Primary RD surgery failure model estimates.

Table 3.  

Covariate SF6 gas C2F6 gas C3F8 gas Air Light oil Heavy oil Overall
Number of operations 2524 1711 681 47 447 98 5508
Patient age (years)
   45 to 64 1399 (55.4) 910 (53.2) 328 (48.2) 18 (38.3) 182 (40.7) 36 (36.7) 2873 (52.2)
   65 to 79 886 (35.1) 582 (34.0) 249 (36.6) 12 (25.5) 165 (36.9) 45 (45.9) 1939 (35.2)
   ≥80 114 (4.5) 107 (6.3) 53 (7.8) 2 (4.3) 50 (11.2) 10 (10.2) 336 (6.1)
   <45 125 (5.0) 112 (6.5) 51 (7.5) 15 (31.9) 50 (11.2) 7 (7.1) 360 (6.5)
Location of largest break
   9–3 O’clock 2306 (91.4) 1110 (64.9) 266 (39.1) 29 (61.7) 253 (56.6) 21 (21.4) 3985 (72.3)
   4 or 8 O’clock 128 (5.1) 257 (15.0) 119 (17.5) 8 (17.0) 54 (12.1) 11 (11.2) 577 (10.5)
   5–7 O’clock 88 (3.5) 338 (19.8 290 (42.6) 10 (21.3) 137 (30.6) 66 (67.3) 929 (16.9)
   No break found 2 (<0.1) 6 (0.4) 6 (0.9) 0 (0.0) 3 (0.7) 0 (0.0) 17 (0.3)
Inferior clock hours detached
   <3 h 1961 (77.7) 979 (57.2) 207 (30.4) 28 (59.6) 99 (22.1) 7 (7.1) 3281 (59.6)
   3–5 h 357 (14.1) 492 (28.8) 266 (39.1) 16 (34.0) 112 (25.1) 49 (50.0) 1292 (23.5)
   6 h 206 (8.2) 240 (14.0) 208 (30.5) 3 (6.4) 236 (52.8) 42 (42.9) 935 (17.0)
Total RD
   No 2463 (97.6) 1630 (95.3) 594 (87.2) 47 (100.0) 297 (66.4) 91 (92.9) 5122 (93.0)
   Yes 61 (2.4) 81 (4.7) 87 (12.8) 0 (0.0) 150 (33.6) 7 (7.1) 386 (7.0)
PVR grade
   None, A or B 2483 (98.4) 1600 (93.5) 597 (87.7) 44 (93.6) 274 (61.3) 60 (61.2) 5058 (91.8)
   C 41 (1.6) 111 (6.5) 84 (12.3) 3 (6.4) 173 (38.7) 38 (38.8) 450 (8.2
Cryotherapy used during surgery
   No 372 (14.7) 315 (18.4) 89 (13.1) 2 (4.3) 160 (35.8) 39 (39.8) 977 (17.7)
   Yes 2152 (85.3) 1396 (81.6) 592 (86.9) 45 (95.7) 287 (64.2) 59 (60.2) 4531 (82.3)
Vitrectomy gauge used
   20 g 97 (3.8) 30 (1.8) 23 (3.4) 0 (0.0) 32 (7.2) 10 (10.2) 192 (3.5)
   23 g 1298 (51.4) 1161 (67.9) 476 (69.9) 8 (17.0) 323 (72.3) 58 (59.2) 3324 (60.3)
   25 g 1072 (42.5) 452 (26.4) 160 (23.5) 5 (10.6) 83 (18.6) 27 (27.6) 1799 (32.7)
   27 g 27 (1.1) 49 (2.9) 3 (0.4) 1 (2.1) 5 (1.1) 3 (3.1) 88 (1.6)
   Not recorded 30 (1.2) 19 (1.1) 19 (2.8) 33 (70.2) 4 (0.9) 0 (0.0) 105 (1.9)

Table 3. Tamponade use for the primary RD surgery failure risk factor model covariates.

SF6 = Sulphur hexafluoride gas.
C2F6 = Perfluoroethane gas.
C3F8 = Perfluoropropane gas.

CME

Stratifying the Risk of Re-detachment: Variables Associated With Outcome of Vitrectomy for Rhegmatogenous Retinal Detachment in a Large UK Cohort Study

  • Authors: David Yorston, FRCOphth; Paul H.J. Donachie, MSc; D.A. Laidlaw, MD, FRCOphth; David H. Steel, MD, FRCOphth; G.W. Aylward, MD, FRCOphth; Tom H. Williamson, MD, FRCOphth
  • CME Released: 3/27/2023
  • Valid for credit through: 3/27/2024
Start Activity

  • Credits Available

    Physicians - maximum of 1.00 AMA PRA Category 1 Credit(s)™

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for ophthalmologists and other clinicians who treat and manage patients with rhegmatogenous retinal detachment.

The goal of this activity is for learners to be better able to describe variables associated with primary anatomical outcome after vitrectomy and internal tamponade for rhegmatogenous retinal detachment.

Upon completion of this activity, participants will:

  1. Assess variables associated with primary anatomical outcome (anatomical failure within 6 months of surgery) after vitrectomy and internal tamponade for rhegmatogenous retinal detachment, based on a retrospective analysis of prospectively collected data
  2. Evaluate risk stratification using a multivariate logistic regression model incorporating variables associated with anatomical failure within 6 months of rhegmatogenous retinal detachment surgery, based on a retrospective analysis of prospectively collected data
  3. Determine the clinical implications of variables associated with primary anatomical outcome (anatomical failure within 6 months of surgery) after vitrectomy and internal tamponade for rhegmatogenous retinal detachment, based on a retrospective analysis of prospectively collected data


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


Faculty

  • David Yorston, FRCOphth

    Gartnavel Hospital
    Glasgow, Scotland

  • Paul H.J. Donachie, MSc

    Gloucestershire Hospitals NHS Foundation Trust
    Cheltenham, United Kingdom
    The Royal College of Ophthalmologists
    National Ophthalmology Database Audit
    London, United Kingdom

  • D.A. Laidlaw, MD, FRCOphth

    Guy's and St. Thomas' NHS Foundation Trust
    London, United Kingdom

  • David H. Steel, MD, FRCOphth

    Sunderland Eye Infirmary
    Sunderland, United Kingdom

  • Bioscience Institute

    Newcastle University
    Newcastle Upon Tyne, United Kingdom

  • G.W. Aylward, MD, FRCOphth

    Moorfields Eye Hospital City Road
    London, United Kingdom

  • Tom H. Williamson, MD, FRCOphth

    Guy's and St. Thomas' NHS Foundation Trust
    London, United Kingdom

CME Author

  • Laurie Barclay, MD

    Freelance writer and reviewer
    Medscape, LLC

    Disclosures

    Laurie Barclay, MD, has the following relevant financial relationships:
    Formerly owned stocks in: AbbVie Inc.

Editor

  • Sobha Sivaprasad, MD

    Editor, Eye

Compliance Reviewer

  • Leigh Schmidt, MSN, RN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, this activity has been planned and implemented by Medscape, LLC and Springer Nature. Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this Journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Eye
CME

Stratifying the Risk of Re-detachment: Variables Associated With Outcome of Vitrectomy for Rhegmatogenous Retinal Detachment in a Large UK Cohort Study

Authors: David Yorston, FRCOphth; Paul H.J. Donachie, MSc; D.A. Laidlaw, MD, FRCOphth; David H. Steel, MD, FRCOphth; G.W. Aylward, MD, FRCOphth; Tom H. Williamson, MD, FRCOphthFaculty and Disclosures

CME Released: 3/27/2023

Valid for credit through: 3/27/2024

processing....

Abstract and Introduction

Abstract

INTRODUCTION: To identify variables associated with primary anatomical outcome following vitrectomy and internal tamponade for rhegmatogenous retinal detachment (RD).

METHODS: A retrospective analysis of prospectively collected data, using a database of RD treated with vitrectomy and internal tamponade. Collected data complied with the RCOphth Retinal Detachment Dataset. The main outcome measure was anatomical failure within six months of surgery.

RESULTS: There were 6377 vitrectomies. 869 eyes were excluded, either because no outcome was recorded, or inadequate follow up, leaving 5508 operations for analysis. 63.9% of patients were male, and the median age was 62. Primary anatomical failure occurred in 13.9%. On multivariate analysis, the following were associated with increased risk of failure: age <45, or >79, inferior retinal breaks, total detachment, one quadrant or greater inferior detachment, low density silicone oil, and presence of proliferative vitreoretinopathy. C2F6 tamponade, cryotherapy, and 25 G vitrectomy, were associated with reduced risk of failure. The area under the receiver operator curve was 71.7%. According to this model, 54.3% of RD are at low risk (<10%), 35.6% are at moderate risk (10–25%), and 10.1% are at high risk (>25%) of failure.

CONCLUSIONS: Previous attempts to identify high risk RD have been limited by small numbers, the inclusion of both scleral buckling and vitrectomy, or by excluding some types of RD. This study examined outcomes in unselected RD, treated by vitrectomy. Identification of the variables associated with anatomical outcome after RD surgery enables accurate risk stratification, which is valuable for patient counselling and selection, and for future clinical trials.

Introduction

Some of the factors that affect anatomical success after retinal detachment (RD) surgery are relatively well understood, and grading systems have been produced that enable surgeons to predict the likelihood of anatomical re-attachment with a single operation[1–6]. However, some of these publications include both scleral buckling and vitrectomy[1, 4, 7, 8] The risk factors for failure are unlikely to be the same for these very different operations. Other reports have only included sub-sets of primary retinal detachments[3, 7], or have included re-operations[8]. Various different outcomes and definitions of anatomical success have been used[4, 5, 8]. Overall, the number of eyes included in each study has been small, Q1 -Q5 with only one report including more than 1 000 eyes[8].

Previous authors have shown that the risk of primary anatomical failure may be increased by proliferative vitreoretinopathy (PVR)[3–6, 8], a greater extent of retinal detachment[3, 4, 9], foveal detachment[10] or total detachment[5, 8], the number of breaks in detached retina[5, 7], inferior breaks[5], the size of breaks[7], pseudophakia[3], hypotony or choroidal detachment[8], and the use of cryotherapy[7]. It is not surprising that there is little agreement between these studies, given the different inclusion criteria, interventions, and end-points, and the relatively small numbers of cases included.

In order to identify, and quantify, the variables associated with anatomical outcome of primary RD treated by pars plana vitrectomy and internal tamponade, we examined data from 5508 primary RD operations. In contrast to some of the other studies of risk factors, we included all primary rhegmatogenous RD, and used the outcome of primary anatomical failure, as this has been shown to be associated with worse functional outcomes.[11, 12]